Cell and Gene Logistics

31. Optimizing Storage Solutions For Allogeneic iPSCs 2/13/2025

    This timely discussion from Cell & Gene Live explored the latest advancements in automation and storage solutions, with a particular focus on tailored cryopreservation techniques for induced pluripotent stem cells (iPSCs).

32. The Future Of Gene Therapy Logistics – A Pivotal Moment 2/4/2025

    Ensure the safe, reliable, and future-ready delivery of gene therapies with cutting-edge temperature-controlled logistics solutions.

33. Supporting Compliance And Reducing Risk In Gene Therapy Logistics 2/4/2025

    Ensure the safe, compliant, and seamless delivery of gene therapies by leveraging advanced logistics solutions designed to meet stringent regulatory standards and mitigate risk at every stage.

34. Reflecting On A Milestone Year For Cell And Gene Therapies 2/3/2025

    Examine the significant CGT advancements in 2024, including new approvals for solid tumors and diabetes treatments, as well as the role of AI and logistical improvements in scaling these therapies.

35. Outsourcing To ISO 17025 Accredited Suppliers 1/28/2025

    Discover the advantages of outsourcing equipment calibration to ISO 17025 accredited suppliers, including cost efficiency and regulatory assurance, in our detailed analysis. Read more to transform your calibration processes.

36. Digital Certificates Of Analysis: A Vision For The Transfer Of Quality Data 1/23/2025

    The pharma/biotech industry must ramp up adoption of digital certificates of analysis, which are transforming the way quality data is transferred between organizations in the supply chain.

37. Quality Roundtable: Raw Material Planning For Tech Transfer And Scaling Biologics 1/22/2025

    Join this roundtable of biopharmaceutical professionals as they share their insights to help you navigate important quality and planning decisions for the progression of your biologic.

38. Upgrading The Vial/Vein-To-Vein Process With Enterprise-Level Digital Infrastructure 1/21/2025

    The cell and gene therapy's value chain has come to be known as the vein-to-vein/vial-to-vein process. Enterprise-level digital infrastructure can address the sector's challenges in a variety of ways.

39. The Importance Of Quality In Raw Material Selection 1/16/2025

    Learn how to select high-quality raw materials for cell-based manufacturing in this exploration of the criticality of raw materials, from preclinical development to commercialization. 

40. Embracing Digital Transformation In Life Science Manufacturing: A Path To Excellence 1/13/2025

    Discover how life science manufacturers are supported in digital transformation, offering solutions for automation, data integration, and compliance to optimize operations.